Skip to content

Addiction research published in 2022

Page 5 of 5: studies 81 to 89 of 89, newest first. Back to the addiction overview

Studies

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review - CORRIGENDUM.

BJPsych Open January 18, 2022 Zach Walsh, Özden Merve Mollaahmetoğlu, Joseph M. Rootman et al. 28 citations

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

DOI: 10.1192/bjo.2022.5 (opens in new tab) Full text (opens in new tab) Ketamine therapy Ketamine treatment Ketamine application Ketamine use +12

Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder

American Journal of Psychiatry January 11, 2022 Meryem Grabski, Amy Mcandrew, Will Lawn et al. 169 citations

OBJECTIVE: Early evidence suggests that ketamine may be an effective treatment to sustain abstinence from alcohol. The authors investigated the safety and efficacy of ketamine compared with placebo in increasing abstinence in patients with alcohol use disorder. An additional aim was to pilot ketamine combined with mindfulness-based relapse prevention therapy compared with ketamine and alcohol...

Mindfulness based stress reduction among substance abuse patients at de-addiction center.

Bioinformation 2022 D Alfred Solomon, S KalaBarathi, R Vijayaraghavan et al.

It is of interest to investigate the effectiveness of a mindfulness-based stress reduction program on stress and salivary cortisol among substance abuse patients. There were 60 drug addicts who were receiving treatment at the addiction centre. Samples are divided into 30 drug abuse patient experimental and 30 substance abuse patient control groups using the simple random sampling approach....

Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.

Current Topics in Behavioral Neurosciences 2022 Nathalie M. Rieser, Marcus Herdener, Katrin H. Preller

Substance use disorders (SUD) represent a significant public health issue with a high need for novel and efficacious treatment options. In light of this high unmet need, recent results reporting beneficial outcomes of psychedelic-assisted therapy in SUD are particularly relevant. However, several questions remain with regard to this treatment approach. The clinical mechanisms of action of...

Why was early therapeutic research on psychedelic drugs abandoned?

Psychological Medicine 2022 Wayne Hall

Advocates of the therapeutic use of psychedelic drugs have argued that a promising approach to treatment was prematurely abandoned in the 1960s primarily because of Richard Nixon's 'War on Drugs'.This paper (1) briefly describes research in the 1950s and 1960s in North America on the use of LSD to treat alcohol dependence, anxiety in terminal illness, and anxiety and depression; and (2)...

Ontology and Politics: Interdependence and Radical Contingency in Merleau-Ponty's Political Interworld.

Human Studies 2022 Anya Daly

This paper takes as its point of departure Merleau-Ponty's assertion: "everything will have to begin again, in politics as well as in philosophy". In pursuing his later work, Merleau-Ponty signalled the need for a reconfiguration of his philosophical vision, so it was no longer caught in Cartesianism and the philosophy of consciousness. This required a turn towards ontology through which he...

DOI: 10.1007/s10746-022-09628-4 (opens in new tab) Full text (opens in new tab) Contingency Democracy Humanism Interdependence +3

Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation

Current Topics in Behavioral Neurosciences 2022 Matthew W. Johnson 31 citations

This manuscript reviews research suggesting that classic psychedelics (5-HT2A receptor agonists) are effective in treating addictions including tobacco use disorder. I review historical research from the 1950s to 1970s suggesting that classic psychedelics are associated with addiction recovery across pharmacologically distinct drugs of addiction. I then review anthropological reports about...

Safety of ibogaine administration in detoxification of opioid-dependent individuals: a descriptive open-label observational study.

Addiction 2022 Thomas Knuijver, Arnt Schellekens, Maarten Belgers et al. 49 citations

Ibogaine is an indole alkaloid used in rituals of the African Bwiti tribe. It is also used in non-medical settings to treat addiction. However, ibogaine has been linked to several deaths, mainly due to cardiac events called torsades des pointes preceded by QTc prolongation as well as other safety concerns. This study aimed to evaluate the cardiac, cerebellar and psychomimetic safety of ibogaine...

Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.

Frontiers in Psychiatry 2022 Udo Bonnet, Michael Specka, Ann-Kristin Kanti et al. 4 citations

There is a lack of benefit/harm assessments of illicit and licit psychoactive substances performed by substance-dependent users in comparison to addiction medicine experts. We extended the analyses of substance harm/benefit assessments of German addiction medicine experts (N = 101), in parts reported recently in this journal [doi.org/10.3389/fpsyt.2020.59219], by the perspectives of...